849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ganglioside-Monosialic Acid Breast Cancer	Sun Yat-sen University	P3	CCC (48)
Glsi-100 Breast Cancer	Greenwich LifeSciences, Inc.	P3	CCC (48)
hlx11 Breast Cancer	Shanghai Henlius Biotech	P3	CCC (48)
hs627 Breast Cancer	BioRay Pharmaceutical Co., Ltd.	P3	CCC (48)
Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain Breast Cancer	Genmab	P1/2	CCC (48)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer Breast Cancer	Stephen Shiao	P2	CCC (48)
Investigational Drug: Recombinant Anti-Her2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates For Breast Cancer	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	P3	CCC (48)
Ivonescimab Breast Cancer	Akeso	P2	CCC (48)
js105 Breast Cancer	Risen (Suzhou) Pharma Tech Co., Ltd.	P3	CCC (48)
Ladiratuzumab Vedotin Breast Cancer	Hoffmann-La Roche	P2	CCC (48)
Lornoxicam Breast Cancer	Fudan University	P3	CCC (48)
Lutetium-177-Dotaga-Iac Breast Cancer	Advanced Imaging Projects, LLC	P1/2	CCC (48)
Mannitol Breast Cancer	National Taiwan University Hospital	P1/2	CCC (48)
Montanide Isa 51 Breast Cancer	ExpreS2ion Biotechnologies	P1/2	CCC (48)
Nuvastatic Breast Cancer	Natureceuticals Sdn Bhd	P3	CCC (48)
Oxybutynin Breast Cancer	Reinier de Graaf Groep	P3	CCC (48)
Pegyinterferon-Alfa-2A Breast Cancer	BriaCell Therapeutics Corporation	P2	CCC (48)
Pemigatinib Breast Cancer	Tianjin Medical University Cancer Institute and Hospital	P2	CCC (48)
PF-07850327 Breast Cancer	Pfizer	P3	CCC (48)
Piflufolastat Breast Cancer	M.D. Anderson Cancer Center	P2	CCC (48)
Pioglitazone Breast Cancer	Rambam Health Care Campus	P2	CCC (48)
Poly((N-(2-Hydroxypropyl)Methacrylamide)-Co-(Methacryloyl-Gly-Phe-Leu-Gly Amide With O-((Trans-4-Aminocyclohexyl)Carbamoyl)Fumagillol)) (~0.91:0.09 X) Breast Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (48)
Pravastatin Breast Cancer	Institut du Cancer de Montpellier - Val d'Aurelle	P2	CCC (48)
Pyruvate Breast Cancer	Rigshospitalet, Denmark	P2	CCC (48)
Riluzole Breast Cancer	University of California, Irvine	P2	CCC (48)
Rilvegostomig Breast Cancer	AstraZeneca	P2	CCC (48)
Shr-A2009 Breast Cancer	Fudan University	P2	CCC (48)
Star0602 Breast Cancer	Marengo Therapeutics, Inc.	P1/2	CCC (48)
Tart Cherry Breast Cancer	Philip Chang	P2	CCC (48)
T-Dxd Breast Cancer	Peking University Cancer Hospital & Institute	P2	CCC (48)
Tegtociclib Breast Cancer	Pfizer	P2	CCC (48)
Teonanacatl Breast Cancer	Psyence Australia Pty Ltd	P2	CCC (48)
tol2506 Breast Cancer	Tolmar Inc.	P3	CCC (48)
vb15010 Breast Cancer	Zhejiang Yangli Pharmaceutical Technology Co., Ltd.	P1/2	CCC (48)
Viosterol Breast Cancer	Jiuda Zhao	P3	CCC (48)
Zimberelimab Breast Cancer	H. Lee Moffitt Cancer Center and Research Institute	P1/2	CCC (48)
9mw2821 Breast Cancer	Fudan University	P2	CC (47)
Adebelizumab Breast Cancer	Henan Cancer Hospital	P2	CC (47)
ak146d1 for Breast Cancer	Akeso	P2	CC (47)
Autologous Immune Cells Breast Cancer	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P1/2	CC (47)
Belzutifan Breast Cancer	Merck Sharp & Dohme LLC	P2	CC (47)
Ebnk-001 Breast Cancer	Essen Biotech	P1/2	CC (47)
Fluvustat Breast Cancer	Shandong Suncadia Medicine Co., Ltd.	P1/2	CC (47)
hb1801 Breast Cancer	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P2	CC (47)
Hrs-2189 Breast Cancer	Jiangsu HengRui Medicine Co., Ltd.	P1/2	CC (47)
Humanized Monoclonal Anti-Fgfr1 Antibody Om-Rca-01 Breast Cancer	Kidney Cancer Research Bureau	P1/2	CC (47)
Interleukin-15 Breast Cancer	Essen Biotech	P1/2	CC (47)
Inv-6452 Breast Cancer	Shenzhen Ionova Life Sciences Co., Ltd.	P1/2	CC (47)
Ivarmacitinib Breast Cancer	Fudan University	P2	CC (47)
Mecapegfilgrastim Breast Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P2	CC (47)

Showing 351 to 400 of 849 assets

PreviousPage 8 of 17Next